Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of 20 ml Cerebrolysin in vascular dementia has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Ever Neuro Pharma GmbH | Conditions: Vascular Dementia | Phase 4 | Status: COMPLETED | Results posted: 2009-07-28